PARP10 and neoplasm: Our findings revealed that NIPAL1 expressionconsistently declined as the disease progresses, suggesting a potentialinvolvement of NIPAL1 in cancer progression, including invasion and metastasis.Conversely, the expression levels of PARP10 and ZYG11B remained relativelystable throughout the course of the tumor (Figure2 c ).